St. Jude wins European OK for brain implant to treat Dystonia
April 10 (Reuters) - St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
The maker of heart pacemakers, valves and other medical devices said European regulators approved its Brio, Kibra and LibraXP deep brain stimulation systems for managing symptoms of the incurable disease.
Dystonia causes a person's muscles to involuntarily contract and spasm, and can leave its victims wheelchair-bound.
- Children's corpses in Korean ferry reveal desperate attempts to escape |
- Obama reassures Japan, other allies on China ahead of visit |
- Ukraine government resumes offensive, hopes for more U.S. help |
- Ukraine president calls for new anti-rebel offensive as crisis deal falters |
- Search for MH370 reveals a military vulnerability for China